Showing results (3831-3840 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 3, 2007
Controlled delivery of peptides and proteinsI Tuncer Degim, Nevin CelebiCurrent Pharmaceutical Design|February 3, 2007
Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?Asterios Karagiannis, Dimitri P Mikhailidis, Anna I Kakafika, et al.Current Pharmaceutical Design|November 15, 2006
Enantiodiscrimination by NMR spectroscopyGloria Uccello-Barretta, Federica Balzano, Piero SalvadoriCurrent Pharmaceutical Design|November 15, 2006
'Toll' gates for future immunotherapyKen J Ishii, Satoshi Uematsu, Shizuo AkiraCurrent Pharmaceutical Design|November 15, 2006
Molecular basis for invertebrate innate immune recognition of (1-->3)-beta-D-glucan as a pathogen-associated molecular patternT MutaCurrent Pharmaceutical Design|November 15, 2006
Innate immunity in the mucosal immune systemTomonori Nochi, Hiroshi KiyonoCurrent Pharmaceutical Design|November 15, 2006
Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular diseaseLynn L Stoll, Gerene M Denning, Neal L WeintraubCurrent Pharmaceutical Design|November 15, 2006
In vitro infection of human monocyte-derived dendritic cells with Candida albicans: receptorial involvement and therapeutic implicationsMaria Pepe, Emilio Jirillo, Vito CovelliCurrent Pharmaceutical Design|June 22, 2006
Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeuticsAnne Pumfery, Cynthia de la Fuente, Reem Berro, et al.Pageof 1,008